EN
HI
Jenburkt Pharmaceuticals share price chart
Jenburkt Pharmaceuticals Share Key Metrics
Volume
1103.00
Market Cap
453.91 CR
LTQ@LTP
3@1028.50
ATP
1035.79
Var Margin
17.92 %
Circuit Range
836.4-1254.6
Delivery %
89.8 %
Value
11.42 L
ASM/GSM
No
Market Lot
1
Summary
JENBURPH stock price is ₹1028.5 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹1027.00 and ₹1048.00, while Jenburkt Pharmaceuticals share price 52 week high low is ₹1027.00 & ₹1073.90.
In terms of trading activity, JENBURPH share price has recorded a volume of 1,103 shares. The Jenburkt Pharmaceuticals has a market cap of ₹4413300. The stock’s Average Traded Price (ATP) stands at ₹1035.79, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹1028.50.
The Jenburkt Pharmaceuticals upper circuit limit is ₹1254.60 & The Jenburkt Pharmaceuticals lower circuit limit is ₹836.40, with a Value of ₹11.42 L. The Delivery Percentage for the day is 89.8%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Jenburkt Pharmaceuticals Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.06
Sector P/B
3.36
Sec. Div. Yield
0.51
Jenburkt Pharmaceuticals Resistance and Support
Pivot 1050.13
Resistance
First Resistance
1055.26
Second Resistance
1065.03
Third Resistance
1070.16
Support
First Support
1040.36
Second Support
1035.23
Third Support
1025.46
Jenburkt Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 21 2026 | 1042.7 | 1028.5 | -1.63% | 1048 | 1027 |
| Thu Aug 20 2026 | 1050.19 | 1045.5 | -0.84% | 1059.9 | 1045 |
| Wed Aug 19 2026 | 1064 | 1054.4 | 0.68% | 1064.9 | 1045 |
Jenburkt Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-05-05 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Jenburkt Pharmaceuticals News
Jenburkt Pharmaceuticals Ltd - 524731 - Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter Ended On 30Th June, 2026.
Jenburkt Pharma board will convene on August 6, 2026, to consider and approve its Q1 FY27 standalone financial results. This meeting is for the quarter ended June 30, 2026.
Jul 29 2026 17:29:18
Jenburkt Pharmaceuticals Management
| Name | Position |
|---|---|
| Ashish U Bhuta | Chairman & Managing Director |
| Dilip H Bhuta | Whole Time Director & Chief Financial Officer |
Jenburkt Pharmaceuticals FAQs
The Buying Price of Jenburkt Pharmaceuticals share is 1028.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Jenburkt Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jenburkt Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Jenburkt Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Jenburkt Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Jenburkt Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.06 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Jenburkt Pharmaceuticals is 453.91 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Jenburkt Pharmaceuticals share price is 1073.90 & 1027.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Jenburkt Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
